MiMedx: Flying Too Close To The Sun - Aurelius Value
We see large undiscounted channel stuffing and kickback risks lurking beneath the surface at MiMedx (NASDAQ: MDXG)
Looking for OSIR and My Oh My Medex to swap market caps.
As awful as this dragging on is, I foresee many HUGE parties when we get up-to-date (and re-listed.) . Just saying folks!
I know one thing that I am 100% sure of, all those Sundays I was told and brought up to be patient and pray has been put to the test for this stock, Amen !!
Well only 8 trading days left till something has to happen as I believe Oct 3rd was last day given to deliver financials. Was so hoping it would be today. Would think at least they could give an update. But we should know soon enough.
Difficult to give options without exact info and that info is only in the books. Looks like E&Y has done it's work by now. The board has evidently seen the books and had their official meeting yesterday. So they must have accepted the books and perhaps thought what follows: proposals for annular meetings including the publishing the books etc. Only my hope all this happened yesterday.
Maybe they follow up tonight, at least they are alive !
Getting frustrated ... throw us a freakin' bone!!
SEE WHO'S ATTENDING On October 4-6, we will hear what OSIRIS has to say. The 2017 Cell & Gene Meeting on the Mesa is only two weeks away! Leaders from the following companies and organizations will be in La Jolla on October 4-6, will you? Register now to secure your place at the cell and gene therapy sector's premier annual conference.
4D Molecular Therapeutics AABB Abeona Therapeutics ACF Bioservices Acucela Adaptimmune Adjuvant Partners Adverum Biotechnologies AGTC Ajinomoto North America Akron Biotech Aldevron All India Institute of Medical Sciences AllCells Allergan Alliance for Regenerative Medicine AlloSource American Gene Technologies Amnion Foundation Anthem ASBMT ASGCT Asklepios Biopharmaceutical Astellas Pharma Asterias Biotherapeutics Atara Biotherapeutics Athersys Audentes Therapeutics Avectas Avery Therapeutics AveXis AVM Biotechnology AVROBIO AxoGen Bank of America Merrill Lynch Baylor University Be the Match BioTherapies Becton Dickinson Beijing Genomics Institute Bellicum Pharmaceuticals Benitec Biopharma BioInsights Publishing BioLife Solutions Biological Industries USA BioMarin BioMedGPS bioMerieux BioreclamationIVT Biostage BioTime BloodCenter of Wisconsin Blood Systems Bloodworks bluebird bio BlueRock Therapeutics B-MoGen Biotechnologies Bone Therapeutics Boston Biomedical Associates Boston Scientific BrainXell Brammer Bio Brooks Life Science Systems BridgeBio Pharma Buck Institute for Research on Aging CA Department of Public Health Cal Poly San Luis Obispo Caladrius Biosciences Calibr Capricor Therapeutics CarthaGenetics Suisse Sàrl Catalyst Advisors CCRM Cell and Gene Therapy Catapult Cell Innovation Partners Limited Cell Medica Cell Therapies Pty. CellGenix Cells for Cells CellSeed Cellular Dynamics International Celsense Cesca Therapeutics Charter Medical Children's Hospital LA Chromocenter CIRM City of Hope CJ Partners ClearView Healthcare Partners Cleveland Clinic Foundation CMIC Holdings Cognate Bioservices College of Engineering, Pune CombiGene Consulate General of France CRISPR Therapeutics Cryoport CSL Behring CSU San Marcos CTI Clinical Trial and Consulting Cynata Therapeutics Cynity Cytonome D&P Bioinnovations Danaher DEFTA Partners Department of Commerce Diamond Pharma Services Dignity Health DiscGenics Dohmen Life Science Services Draper EBD Group Editas Medicine EMD Millipore ERA Consulting UK EUFETS Evidera Fate Therapeutics Fibrocell Science FIRM Fortress Biotech F-Prime Capital Fraunhofer Institute Fred Hutchinson Cancer Center FreeMind Group Fresenius Kabi GammaDelta Therapeutics GE Healthcare GenCure Genea Biocells GenEdit George Washington University GlaxoSmithKline Glycostem Gravitas Biomanufacturing GSRAC H.C. Wainwright Harvard University HBRI Healios K.K. Histogenics Hitachi Holland & Knight Homology Medicines Hospital Israelita Albert Einstein Human Longevity Hybrid Concepts ICER ICS - AmerisourceBergen Informa Inotek Pharmaceuticals Innovative Blood Resources Institute for Genomic Medicine Integrium Intellia Therapeutics Invetech Irvine Scientific ISCT ISSCR Janssen R&D Japanese Society for RM jCyte Johnson & Johnson Juno Therapeutics Juventas Therapeutics Kawasaki Heavy Industries KBI Biopharma Kissei America Kyoto University Lake Street Capital Markets LMRI LogicBio Therapeutics Lonza Lovelace Biomedical Lung Institute Lysogene MAK-SYSTEM Mallinckrodt MaSTherCell MaxCyte Mayo Clinic McKesson MedCision Medeor Therapeutics MEDINET MEDIPOST America Medpace MedPOINT Management Medtronic Mesoblast METI MHLW Mill Creek Life Sciences MilliporeSigma MiMedx Group MolMed Myonexus Therapeutics National Marrow Donor Program National PKU Alliance National Search Associates NDA Advisory Services NDRI New York Blood Center NIH Nikon Cell Innovation Nohla Therapeutics Novadip Biosciences Novartis Novasep NSVascular NuTech Medical NYSCF Oklahoma Blood Institute Olympus Opsis Therapeutics Orbsen Therapeutics Orchard Therapeutics Organovo ORIG3N Osiris Therapeutics Oxford BioMedica Pall Life Sciences Parker Hannifin PCT Pepper Hamilton PersImmune Pfizer Phacilitate PharmaCell PMDA PMI Preclinical POC Clinical Research Precision BioSciences Prevail Partners Promethera Biosciences Propagenix Pukana Partners Qiming Venture Partners Quad Technologies QuintilesIMS Regenerex Regeneron REGENXBIO ReNeuron Renova Therapeutics ReproCELL RLB Consulting ROHTO Pharmaceutical RoosterBio Roslin Cell Therapies RTW Investments RxGen Salk Institute for Biological Studies San Diego State University San Diego Union Tribune San Diego Zoo Institute San Raffaele Telethon Institute SanBio Sanford Burnham Prebys Sanford Consortium Sangamo Therapeutics Sanofi Santa Fe Christian School Sapporo Medical University Sartorius Stedim Biotech Save The Cord Foundation SAVSU Technologies Scinogy SCM Lifescience Scottish Development International Scrip/The Pink Sheet Semma Therapeutics SENS Research Foundation Sentien Biotechnologies SERVA Electrophoresis Shire Sigilon Therapeutics Sistemic Limited Southland Corporation Spark Therapeutics Stanford University StemBios Technologies StemBioSys Steminent Biotherapeutics StemoniX Sumitomo Dainippon Pharma Summit for Stem Cell Foundation Supporting Science Switch Bio Synpromics Takeda Pharmaceuticals Terumo BCT Texas Biomedical Research Institute The Scripps Research Institute Thermo Fisher Scientific ThinkCyte TiGenix Tmunity Therapeutics Tolley Health Economics Torrey Pines Institute TrakCel Triumvira Immunologics Tucson Medical Center Tulane University TxCell UC Berkeley UC Irvine UC San Diego UK Dept. for International Trade uniQure Universal Cells University of Arizona University of Massachusetts University of Michigan University of Notre Dame University of Oklahoma University of Oxford University of Pennsylvania US Army Institute US Food and Drug Administration USC Vericel VeriGraft Versant Ventures ViaCyte Vineti Vivet Therapeutics Voisin Consulting Voyager Therapeutics W.L. Gore & Associates Weill Cornell Medicine Weizmann Institute WindMIL Therapeutics WIRB-Copernicus Group World Courier WuXi AppTec Wyss Institute Xenco Medical Xintela AB Yale School of Medicine YposKesi
OSIR could be the biggest comeback ever for any company, from $3 to $100 in 2 years, can I get a BOOOOYAAAAA !!!!
CEOs option were granted on July 10, but Osiris chose to disclose them now. This is not imo a coincidence. Other filings will follow shortly.
While we wait on EY to complete the $OSIR audit, take @biotechfan20 twitter poll on when we think they will report
@biotechfan20 - Búsqueda de Twitter
Los Tweets más recientes de @biotechfan20. Lee lo que las personas están diciendo y únete a la conversación.
Stryker($SYK) promoting use of $OSIR BIO4 for interbody spinal fusion